Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer
IntroductionCDK4/6 inhibitors are cornerstone therapies for advanced HR+/HER2- breast cancer, yet treatment response heterogeneity remains a major clinical challenge. This study integrates single-cell regulatory landscapes with multi-omics data to decode resistance mechanisms and develop predictive...
Saved in:
| Main Authors: | Li Yan, Sijie Chen, Ran Ran, Shidi Zhao, Jing Huang, Jin Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1585574/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting CDK9 for treatment of colorectal cancer
by: Muhammed H. Rahaman, et al.
Published: (2019-10-01) -
Multi-omics analysis reveals the panoramic picture of TOP2A in pan-cancer
by: Jin Zhang, et al.
Published: (2025-02-01) -
Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors
by: Jinming Yang, et al.
Published: (2025-08-01) -
A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
by: Junwei Xiang, et al.
Published: (2023-02-01) -
New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy
by: Wei Dai, et al.
Published: (2025-07-01)